Combination therapy of a type ii anti-cd20 antibody with a...

Details Combination therapy of a type ii anti-cd20 antibody with a... Combination therapy of a type ii anti-cd20 antibody with a...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/69 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2702962

The present invention is directed to the use an type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, espe-cially of CD20 expressing cancers in combination with a proteasome inhibitor.

La présente invention concerne l'utilisation d'un anticorps anti-CD20 de type II en association avec un inhibiteur du protéasome pour la fabrication d'un médicament destiné au traitement du cancer, et particulièrement des cancers exprimant le CD20.

Affiliated with

Also associated with

Rating

Combination therapy of a type ii anti-cd20 antibody with a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy of a type ii anti-cd20 antibody with a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy of a type ii anti-cd20 antibody with a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1515647